Convergen Lifesciences Inc.
AUSTIN, Texas, July 14, 2011 -
Composition of Matter Patent Covers Broad Therapeutic and
Diagnostic Applications
Convergen
LifeSciences, Inc.
AUSTIN, Texas, June 28, 2011 -
> - Patent Covers CNVN202
Nanomolecular Cancer Therapy
Convergen
LifeSciences, Inc.